A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)
Clinical trial NCT01717313 · COMPLETED
Trial details
- NCT number
- NCT01717313
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-05
- Primary completion
- 2015-06-19
- Enrollment
- 329
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.